Literature DB >> 11853411

Uptake and processing of modified bacteriophage M13 in mice: implications for phage display.

Tom J M Molenaar1, Ingrid Michon, Sonja A M de Haas, Theo J C van Berkel, Johan Kuiper, Erik A L Biessen.   

Abstract

Internalization and degradation of filamentous bacteriophage M13 by a specific target cell may have major consequences for the recovery of phage in in vivo biopanning of phage libraries. Therefore, we investigated the pharmacokinetics and processing of native and receptor-targeted phage in mice. (35)S-radiolabeled M13 was chemically modified by conjugation of either galactose (lacM13) or succinic acid groups (sucM13) to the coat protein of the phage to stimulate uptake by galactose recognizing hepatic receptors and scavenger receptors, respectively. Receptor-mediated endocytosis of modified phage reduced the plasma half-life of native M13 (t(1/2) = 4.5 h) to 18 min for lactosylated and 1.5 min for succinylated bacterophage. Internalization of sucM13 was complete within 30 min after injection and resulted in up to 5000-fold reduction of bioactive phage within 90 min. In conclusion, these data provide information on the in vivo behavior of wild-type and receptor-targeted M13, which has important implications for future in vivo phage display experiments and for the potential use of M13 as a viral gene delivery vehicle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853411     DOI: 10.1006/viro.2001.1254

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

Authors:  Caroline Westwater; Laura M Kasman; David A Schofield; Phillip A Werner; Joseph W Dolan; Michael G Schmidt; James S Norris
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

2.  Targeted axonal import (TAxI) peptide delivers functional proteins into spinal cord motor neurons after peripheral administration.

Authors:  Drew L Sellers; Jamie M Bergen; Russell N Johnson; Heidi Back; John M Ravits; Philip J Horner; Suzie H Pun
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-17       Impact factor: 11.205

3.  Targeting antibacterial agents by using drug-carrying filamentous bacteriophages.

Authors:  Iftach Yacoby; Marina Shamis; Hagit Bar; Doron Shabat; Itai Benhar
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Plasma clearance of bacteriophage Qbeta particles as a function of surface charge.

Authors:  Duane E Prasuhn; Pratik Singh; Erica Strable; Steven Brown; Marianne Manchester; M G Finn
Journal:  J Am Chem Soc       Date:  2008-01-05       Impact factor: 15.419

Review 5.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 6.  Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine.

Authors:  Amy M Wen; Pooja H Rambhia; Roger H French; Nicole F Steinmetz
Journal:  J Biol Phys       Date:  2013-04-19       Impact factor: 1.365

7.  Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.

Authors:  Nagesh Pulicherla; Shen Shen; Swati Yadav; Kari Debbink; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

Review 8.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

9.  Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.

Authors:  Fortunato Ferrara; Daniela I Staquicini; Wouter H P Driessen; Sara D'Angelo; Andrey S Dobroff; Marc Barry; Lesley C Lomo; Fernanda I Staquicini; Marina Cardó-Vila; Suren Soghomonyan; Mian M Alauddin; Leo G Flores; Marco A Arap; Richard C Lauer; Paul Mathew; Eleni Efstathiou; Ana M Aparicio; Patricia Troncoso; Nora M Navone; Christopher J Logothetis; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

10.  Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.

Authors:  Karin L Lee; Sourabh Shukla; Mengzhi Wu; Nadia R Ayat; Caroline E El Sanadi; Amy M Wen; John F Edelbrock; Jonathan K Pokorski; Ulrich Commandeur; George R Dubyak; Nicole F Steinmetz
Journal:  Acta Biomater       Date:  2015-03-10       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.